Loading
A phase 2 trial of nivolumab and ipilimumab in colorectal cancer, run by GERCOR - Multidisciplinary Oncology Cooperative Group, now recruiting.
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC is a phase 2, interventional study registered as NCT05310643 by GERCOR - Multidisciplinary Oncology Cooperative Group, with a registry enrolment figure of 30 participants, started 2022-05-05 and due to reach its primary completion in 2025-09. Interventions recorded: Nivolumab; Ipilimumab. Conditions listed: Metastatic Colorectal Cancer. Primary outcome: Objective response rate (ORR) by RECIST 1.1. Colorectal eligibility wording from the registry: "Histologically confirmed colorectal adenocarcinoma,". Sites: France. No results are recorded here; the registry entry is the source.
Shares GERCOR, Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Ipilimumab, Nivolumab, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Ipilimumab, Nivolumab, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Nivolumab, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Nivolumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.